This suggests that phospho-Ser338/339 CXCR4 is not a target of BCR/PKD pathway in CLL cells but more probably a target of Btk/PKC upon CXCL12- or EGF-stimulations [50, 55]. This evidence concerns the gene EGF and B-cell chronic lymphocytic leukemia.